mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.008 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.009 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.01 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |